首页 /
货号 | 靶点 | 种属 | 表达宿主 | 表达区域 | 标签 | 活性 | 纯度 |
---|---|---|---|---|---|---|---|
RP02753 | HLA-E*01:03 Complex Tetramer | Human | HEK293 cells | Gly25-Ile305(HLA-E*01:03),Ile21-Met119(B2M) and VMAPRTLVL peptide | C-His&Avi | ![]() ![]() ![]() | |
RP02665 | FGFR2 beta (IIIb) | Mouse | HEK293 cells | Pro39-Pro263 | C-His | ![]() ![]() | |
RP02699 | KRAS G12D (HLA-A*11:01) | Human | HEK293 cells | Gly25-Thr305(HLA-A*11:01),Ile21-Met119(B2M) and VVVGADGVGK peptide | C-His&Avi | ![]() ![]() | |
RP02700 | KRAS G12D(HLA-A*11:01) Tetramer | Human | HEK293 cells | Gly25-Thr305(HLA-A*11:01),Ile21-Met119(B2M) and VVVGADGVGK peptide | C-His&Avi | ![]() ![]() | |
RP02698 | P53 WT (HLA-A*02:01) Tetramer | Human | HEK293 cells | Gly25-Thr305(HLA-A*02:01),Ile21-Met119(B2M) and HMTEVVRRC peptide | C-His&Avi | ![]() ![]() | |
RP02728 | Cynomolgus CD27 Ligand/CD70 | Cynomolgus | HEK293 cells | Gln39-Pro194 | N-His | ![]() ![]() | |
RP02605 | Latent TGF-beta 1(C33S) | Human | HEK293 cells | Leu30-Ser390(C33S) | N-His&Avi | ![]() ![]() ![]() ![]() | |
RP02732 | ENPP-3(558-875) | Human | HEK293 cells | Lys558-Ile875 | N-His | ![]() ![]() | |
RP02713 | Cynomolgus NKG2A&CD94 | Cynomolgus | HEK293 cells | Pro94-Leu233(NKG2A)&Lys32-Ile179(CD94) | C-His&Flag | ![]() ![]() | |
RP02663 | GM-CSF R alpha | Mouse | HEK293 cells | Leu30-Pro327 | C-His | ![]() ![]() | |
RP02652 | Cynomolgus Serum Albumin | Cynomolgus | HEK293 cells | Asp25-Ala608 | C-His | ![]() ![]() ![]() | |
RP02733 | MARCO | Human | HEK293 cells | Ser405-Val520 | N-His | ![]() ![]() | |
RP02583 | Fc-gamma RI/CD64 | Human | HEK293 cells | Gln16-Pro288 | C-His&Avi | ![]() ![]() ![]() | |
RP02719 | CCL5 | Mouse | HEK293 cells | Ser24-Ser91 | N-hFc | ![]() ![]() | |
RP02562 | Fc-gamma RIII beta/CD16b | Human | HEK293 cells | Gly17-Ser200 | C-His&Avi | ![]() ![]() ![]() |